Erin Bastick, PharmD, RPh
Know these barriers to reduce type 2 diabetes costs
IMS Health study: Up to 15% of healthcare system costs avoidable and effective patient activation by multiple stakeholders is key to driving improvement.
Aggressive blood sugar control slows diabetic eye disease progression
NIH-funded study shows less diabetic retinopathy progression among those who underwent intensive glycemic control.
Patient navigators can benefit diabetes outcomes
Study seeks to determine whether significant improvement in glycemic control can be achieved when regular coaching is part of the process.